Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04911374 · ClinicalTrials.gov registry record · NA
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
A NA study of Wrinkle and Photoaging, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04911374: Completed NA study of Wrinkle and Photoaging, sponsored by Revision Skincare.
NCT04911374 is a NA study of Wrinkle and Photoaging that has completed, run by Revision Skincare. The registered enrollment target is 45 participants, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04911374, a NA study of Wrinkle and Photoaging, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center clinical trial is being conducted to assess the efficacy and tolerability of an anti-aging eye cream and face moisturizer when used over the course of 12 weeks twice-daily by women, 35-65 years, with mild to moderate droopy eyelids, moderate crow's feet wrinkles, and moderate global facial photodamage.
Primary Outcome
The primary efficacy endpoint will be the Investigator Clinical Grading using Modified Griffith's 10-point Scale. A change in scores at week 4, week 8 and week 12 in comparison to baseline indicates an improvement for the indicated parameter. The efficacy parameters will be assessed globally on each subject's face using a modified Griffiths' 10-point scale according to the following numerical definitions (half-point scores may be used as necessary to more accurately describe the skin condition)
Conditions Studied
Interventions
- OTHER Gentle Cleansing Lotion, Revision Skincare
- OTHER Aveeno Face Milk SPF 40+
Study Locations (1)
Texas
- Stephens and Associates - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-09-11 |
| Est. Completion | 2021-02-03 |
| Phase | NA |
What the finished NCT04911374 record still lists
NCT04911374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (62% lower).
The record links to 3 conditions, with Wrinkle appearing as the primary indexed condition, and to 2 interventions - of which Gentle Cleansing Lotion, Revision Skincare is the first listed.
NCT04911374 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04911374 about?
NCT04911374 is a clinical study titled "An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream". This single-center clinical trial is being conducted to assess the efficacy and tolerability of an anti-aging eye cream and face moisturizer when used over the course of 12 weeks twice-daily by women, 35-65 years, with mild to moderate droopy eyelids, moderate crow's feet wrinkles, and moderate glob...
What is the current status of trial NCT04911374?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-09-11. Estimated completion is 2021-02-03.
What conditions does trial NCT04911374 study?
This clinical trial studies the following conditions: Wrinkle, Photoaging, Fine Lines.
What interventions are being tested in trial NCT04911374?
The interventions under investigation include: Gentle Cleansing Lotion, Revision Skincare (OTHER), Aveeno Face Milk SPF 40+ (OTHER).
Who is sponsoring clinical trial NCT04911374?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04911374 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04911374's enrollment target sits among peer trials
45 12th of 25 higher than 14 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI